Quarterly Result25 Feb 2026, 07:33 pm
Sanofi Consumer Healthcare India Ltd Reports Q4 and FY2025 Results, Recommends Dividend, and Appoints Cost Auditor
AI Summary
Sanofi Consumer Healthcare India Ltd announced its quarterly and financial year ended 31st December 2025 results, with a recommended final dividend of Rs. 75/- per equity share. The company also approved the re-appointment of M/s. Kishore Bhatia & Associates, Cost Accountants as Cost Auditor for the Financial Year ending 31 December 2026. The Audited Standalone Financial Statements, Auditor’s Report, Statement of Assets and Liabilities, and Standalone Statement of Cashflows for the year ended 31st December 2025 are enclosed.
Key Highlights
- Sanofi Consumer Healthcare India Ltd reported its Q4 and FY2025 results.
- The company recommended a final dividend of Rs. 75/- per equity share for FY2025.
- M/s. Kishore Bhatia & Associates, Cost Accountants re-appointed as Cost Auditor for FY2026.
- The Audited Standalone Financial Statements, Auditor’s Report, Statement of Assets and Liabilities, and Standalone Statement of Cashflows for FY2025 were released.